IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

2000 • 1,954 citations

Multiple sclerosis

2002 • 1,678 citations

Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets

2015 • 1,440 citations

Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin

2001 • 1,211 citations

Blood-brain barrier disruption in multiple sclerosis

2003 • 617 citations

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis

1997 • 386 citations

Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

1990 • 360 citations

Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo

1998 • 354 citations

Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors

1994 • 350 citations

The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: A serial diffusion MRI study

2000 • 314 citations

Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis

2004 • 265 citations

Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses

1998 • 261 citations

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

1998 • 240 citations

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study

2003 • 217 citations

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

2004 • 184 citations

Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.

1993 • 147 citations

Intravenous immunoglobulin G for the treatment of relapsing–remitting multiple sclerosis: a meta‐analysis

2002 • 116 citations

Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis

2004 • 108 citations

A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2‐weighted spinal cord MRI in a virus‐induced murine model of MS

2004 • 96 citations

No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment

2002 • 84 citations

Intravenous immunoglobulin treatment in multiple sclerosis.

1995 • 79 citations

Brain Size Scaling and Body Composition in Mammals

2003 • 75 citations

Mechanisms of High-Dose Intravenous Immunoglobulins in Demyelinating Diseases

1999 • 71 citations

Immunocytochemical localization of immunoglobulins in the rat brain: Relationship to the blood‐brain barrier

1994 • 69 citations

Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis

2000 • 55 citations

European Study on Intravenous Immunoglobulin in Multiple Sclerosis

2004 • 54 citations

Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein

1998 • 53 citations

Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis - results of a retrospective multicenter observational study over five years

2005 • 47 citations

Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides

2001 • 46 citations

Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis

2005 • 45 citations

Intracellular Metabolic Fate of Radioactivity after Injection of Technetium-99m-Labeled Hydrazino Nicotinamide Derivatized Proteins

1999 • 45 citations

MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)

2005 • 44 citations

Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis

2001 • 41 citations

99mTc human immunoglobulin scintigraphy--a reliable method to detect joint activity in rheumatoid arthritis.

1992 • 40 citations

Other therapy options and future strategies for treating patients with multiple sclerosis

2004 • 40 citations

Suppression of Experimental Autoimmune Encephalomyelitis by Intravenously Administered Polyclonal Immunoglobulins

2000 • 38 citations

In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.

1999 • 37 citations

Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)

1997 • 35 citations

Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease

1993 • 32 citations

The role of intravenous immunoglobulin in the treatment of multiple sclerosis

2003 • 32 citations

Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.

1998 • 25 citations

The distribution of immunoglobulins and albumin in the central nervous system in acute experimental allergic encephalomyelitis

2009 • 22 citations

Intravenous immunoglobulin ameliorates experimental autoimmune encephalomyelitis and reduces neuropathological abnormalities when administered prophylactically

2005 • 22 citations

Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy

2003 • 22 citations

Antibody-mediated Remyelination: Relevance to Multiple Sclerosis

2000 • 18 citations

Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm

1998 • 9 citations

Cited By (0)

No citing papers found in database